Alurar rigakafin Pfizer ya sami amincewar FDA: Shin za mu buƙaci rigakafi na biyu?

Alurar rigakafin MMR: Dabaru mai yuwuwar don Rage Mummuna da Mutuwar Cutar COVID-19

Cutar sankarau da ke haifar da shirye-shiryen kawar da kyanda tare da yawan allurar rigakafin MMR na iya yin bayanin wani ɓangare na bambance-bambancen da aka lura na duniya, yana ba da shawarar cewa rigakafin MMR na iya ba da kariya mai ƙarfi daga yaduwar COVID-19 da mace-mace. Karanta abin da Dr. Ashford ya ce game da batun.

An aiwatar da matakan al'ada na nisantar da jama'a, tsafta kamar wanke hannu - sanya abin rufe fuska, da gano tuntuɓar tare da nasara mai ma'ana. Koyaya, halaye 3 na COVID-19: 1) bambancin duniya; 2) mace-mace masu alaka da shekaru; da 3) jerin homology tsakanin furotin fusion na SARS-CoV-2 da ƙwayoyin cuta na kyanda da mumps, da jerin homology tsakanin sassan Macro na SARS-CoV-2 da ƙwayar cutar rubella, suna ba da shawarar rigakafin cutar kyanda-Mumps-Rubella (MMR). na iya rage yaduwar COVID-19 da tsanani.

Karanta cikakken labarin anan: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583585/

Waɗannan binciken sun ba da shawarar allurar MMR na iya kariya daga COVID-19, gami da mutane masu haɗari, kamar tsofaffi masu kamuwa da cuta, da ma'aikatan kiwon lafiya da masu ba da amsa na farko tare da marasa lafiyar COVID-19, musamman mutanen da ke zaune a wuraren kulawa na dogon lokaci da makamantansu. ma'aikatan hukumomi.

Cutar sankarau da ke haifar da shirye-shiryen kawar da kyanda tare da yawan allurar rigakafin MMR na iya yin bayanin wani ɓangare na bambance-bambancen da aka lura na duniya, yana ba da shawarar cewa rigakafin MMR na iya ba da kariya mai ƙarfi daga yaduwar COVID-19 da mace-mace.